The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Amino acid and glucose metabolism in fed‐batch CHO cell culture affects antibody production and glycosylation
Abstract
Fed‐batch Chinese hamster ovary (CHO) cell culture is the most commonly used process for IgG production in the biopharmaceutical industry. Amino acid and glucose consumption, cell growth, metabolism, antibody titer, and N‐glycosylation patterns are always the major concerns during upstream process optimization, especially media optimization. Gaining knowledge on their interrelations could provide insight for obtaining higher immunoglobulin G (IgG) titer and better controlling glycosylation‐related product quality. In this work, different fed‐batch processes with two chemically defined proprietary media and feeds were studied using two IgG‐producing cell lines. Our results indicate that the balance of glucose and amino acid concentration in the culture is important for cell growth, IgG titer and N‐glycosylation. Accordingly, the ideal fate of glucose and amino acids in the culture could be mainly towards energy and recombinant product, respectively. Accumulation of by‐products such as NH4+ and lactate as a consequence of unbalanced nutrient supply to cell activities inhibits cell growth. The levels of Leu and Arg in the culture, which relate to cell growth and IgG productivity, need to be well controlled. Amino acids with the highest consumption rates correlate with the most abundant amino acids present in the produced IgG, and thus require sufficient availability during culture. Case‐by‐case analysis is necessary for understanding the effect of media and process optimization on glycosylation. We found that in certain cases the presence of Man5 glycan can be linked to limitation of UDP‐GlcNAc biosynthesis as a result of insufficient extracellular Gln. However, under different culture conditions, high Man5 levels can also result from low α‐1,3‐mannosyl‐glycoprotein 2‐β‐N‐acetylglucosaminyltransferase (GnTI) and UDP‐GlcNAc transporter activities, which may be attributed to high level of in the cell culture. Furthermore, galactosylation of the mAb Fc glycans was found to be limited by UDP‐Gal biosynthesis, which was observed to be both cell line and cultivation condition‐dependent. Extracellular glucose and glutamine concentrations and uptake rates were positively correlated with intracellular UDP‐Gal availability. All these findings are important for optimization of fed‐batch culture for improving IgG production and directing glycosylation quality. Biotechnol. Bioeng. 2015;112: 521–535. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829 · cited 2×
“effectors function, immunogenicity, stability, and clearance rate (Burton and Dwek 2006; Goochee et al. 1991; Jefferis 2009a; Jefferis 2009b; Raju 2008).”
BackgroundInfluentialUmaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
Metabolic control of recombinant protein N‐glycan processing in NS0 and CHO cells
Baker, K. N., Rendall, M. H., Hills, A. E., Hoare, M., Freedman, R. B., & James, D. C. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1051 · Cited by 184
Feeding lactate for CHO cell culture processes: Impact on culture metabolism and performance
Li, J., Wong, C. L., Vijayasankaran, N., Hudson, T., & Amanullah, A. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24389 · Cited by 137
Metabolic control of recombinant monoclonal antibody N‐glycosylation in GS‐NS0 cells
Hills, A. E., Patel, A., Boyd, P., & James, D. C. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.10022 · Cited by 127
Druz, A., Son, Y., Betenbaugh, M., & Shiloach, J. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2012.12.004 · Cited by 73
Cited by
Advances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
Ritacco, F. V., Wu, Y., & Khetan, A. (2018) · Biotechnology Progress · doi:10.1002/btpr.2706 · Cited by 273
A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism
Hefzi, H., Ang, K. S., Hanscho, M., Bordbar, A., Ruckerbauer, D., Lakshmanan, M., Orellana, C. A., Baycin-Hizal, D., Huang, Y., Ley, D., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.020 · Cited by 255
Self-citationPereira, S., Kildegaard, H. F., & Andersen, M. R. (2018) · Biotechnology Journal · doi:10.1002/biot.201700499 · Cited by 214
Self-citationFisher, A. C., Kamga, M.-H., Agarabi, C., Brorson, K., Lee, S. L., & Yoon, S. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.08.008 · Cited by 180
Metadata
- Authors
- Fan, Y., Jimenez Del Val, I., Müller, C., Wagtberg Sen, J., Rasmussen, S. K., Kontoravdi, C., Weilguny, D., & Andersen, M. R.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2014-10-10
- Volume
- 112
- Issue
- 3
- Pages
- 521-535
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2157531491
- Cited by
- 217
- References
- 7
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amino acid and glucose metabolism in fed‐batch CHO cell culture affects antibody production and glycosylation. https://app.cochat.ai/papers/10.1002/bit.25450
- The paper
- Fan, Y., Jimenez Del Val, I., Müller, C., Wagtberg Sen, J., Rasmussen, S. K., Kontoravdi, C., Weilguny, D., & Andersen, M. R. (2015). Amino acid and glucose metabolism in fed‐batch CHO cell culture affects antibody production and glycosylation. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.25450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.